Regeneron Pharmaceuticals
TARRYTOWN, NYfiles as REGENERON PHARMACEUTICALS, INC.
$177m in 3 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 64.6% of the portfolio this quarter.
Value
$177m
Stocks
3
Top 10 share
100.0%
Turnover
64.6%
What changed this quarter
New
Bought for the first time this quarter.
- Parabilis MedicinesPBLS64.4% of the fund
- Adicet BioACET0.3% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- Adicet BioACET-100%
Holdings
- Parabilis MedicinesPBLS
- Share
- 64.4%
- Value
- $114m
- Shares
- 4,166,666
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Parabilis MedicinesPBLS | 64.4% | $114m | 4,166,666 | New |
| Intellia TherapeuticsNTLA | 35.4% | $63m | 3,702,995 | Held |
| Adicet BioACET | 0.3% | $522,819 | 60,511 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 88.1% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.